[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@TheRayMyers lol. $spro Tebipenem an oral carbapenem that eliminates hospital stays for cUTI. My targets $7-12 stock is $XXXX. GSK buys them. Do some work"
X Link @Cubswin2022 2025-10-15T17:49Z XXX followers, XX engagements
"@StocksToTrade @timothysykes $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission next w. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:08Z XX followers, XX engagements
"@timothysykes $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission next w. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:07Z XX followers, XX engagements
"@ej23ny $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:05Z XX followers, XX engagements